Biotech Funding Program

Focus Areas: Cell and gene therapy projects with potential for clinical breakthroughs in treatment of:

• Glioblastoma (brain cancer)
• Pancreatic cancer

Why These Cancers: High morbidity rates, low clinical trial success rates, and often struggle to receive support from venture capital and other investors

Funding Criteria

ACGT is specifically seeking projects with:

• Robust scientific foundation
• Clearly defined path to the clinic and patient
• Promise for patients
• Potential for financial return to the organization (to help sustain support of innovative research)

Program Philosophy: Opportunities must offer promise for patients as well as a financial return for the organization to help sustain its support of innovative cancer cell and gene therapy research.

Eligibility

Applicant Type: Biotech companies with cell and gene therapy projects

Contact Information

Chief Program Officer: Barbara Lavery
Organization: Alliance for Cancer Gene Therapy, Inc., a 501(c)(3) organization

Donor Opportunities

If you are a current donor or would like to become one, this program provides opportunities to contribute specifically to the advancement of biotechnology clinical candidates and to see philanthropy pay off in sustainable dollars that advance the mission.

How to Apply

For Biotech Companies:

To learn more about the program and apply:

1. Contact directly:
   • Barbara Lavery, Chief Program Officer
   • Email: blavery@acgtfoundation.org
2. Complete application form:
   • Available on the Biotech Funding Program page
   • Form link referenced as "complete this form" on program page

Note: Specific application requirements, deadlines, and detailed submission instructions not provided in available website content. Applicants should contact Barbara Lavery or complete the online form for complete application details.